Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer (ALTAK)
Prevalence and Risk Factors for Persistent Tobacco or Alcohol Use Over the First Year of a First Lung or Head and Neck Cancer
研究概览
详细说明
Continuing the chronic intoxication by either tobacco or alcohol after the initial diagnosis of a first lung or head and neck cancer significantly improves the risk of experiencing a second cancer, and largely affects the long term survival. Addiction intervention programs should be personalized according to the patient's profile, with the aim to develop more sustained intervention and monitoring in patients identified at higher risk of not spontaneously stopping harmful substance use. As of today, the trajectories of smoking and drinking habits and the risk factors for persisting smoking or drinking habits have been insufficiently explored among patients with a first lung or head and neck cancer.
The ALTAK study aims to depict the rate of tobacco smokers 12 months after the initial diagnosis of a first lung or head and neck cancer. The secondary objectives of the study are:
- to depict the rate of alcohol users 12 months after the initial diagnosis of a H&N cancer
- to depict the rate of tobacco smokers at cancer diagnosis
- to depict the rate of alcohol users at cancer diagnosis
- to determine the social, motivational, psychiatric, tobacco-related, alcohol-related, and cannabis-related features associated with stopping tobacco in the year following the diagnosis of a first TARC.
- to determine the social, psychiatric, tobacco-related, alcohol-related, and cannabis-related features associated with stopping alcohol drinking in the year following the diagnosis of a first H&N cancer
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
-
Lille、法国、59020
- Oscar Lambret Center
-
Lille、法国、59 037
- Centre Hospitalier Régional et Universitaire - Hopital HURIEZ
-
Lille、法国、59 037
- Centre Hospitalier Régional et Universitaire - Hopital CALMETTE
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- first head and neck or lung cancer
- first support
- age ≥ 18
- patient covered by health insurance
- signed informed consent
Exclusion Criteria:
- prior lung or head and neck cancer
- History of another cancer <5 years, not evolutive and untreated at baseline (carcinoma of the cervix, or basal cell carcinoma of the skin properly treated are allowed). The presence of a second discovery tumor location at the same time as the lung or head and neck cancer, is not a criteria for non-inclusion
- mesothelioma and oesophageal cancer
- unable to undergo trail medical follow up (geographical, social and psychological reasons)
- pregnant or nursing women
- patient under guardianship
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
干预/治疗 |
---|---|
head and neck or lung cancer
patient with a first head and neck cancer or first lung cancer
|
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
tobacco consumption
大体时间:at 12 months
|
reported tobacco smoking
|
at 12 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
tobacco smoking
大体时间:at baseline, 3 and 6 months
|
frequency tobacco consumption
|
at baseline, 3 and 6 months
|
alcohol drinking
大体时间:at baseline, 3, 6 and 12 months
|
frequency of alcohol consumption
|
at baseline, 3, 6 and 12 months
|
progression free survival
大体时间:at 12 months
|
median time between date of inclusion and date of first progression
|
at 12 months
|
overall survival
大体时间:at 12 months
|
median time between date of inclusion and date of death
|
at 12 months
|
sociodemographic, cancer-related, tobacco-related, alcohol-related, and psychiatric characteristics
大体时间:at baseline
|
at baseline
|
合作者和调查者
调查人员
- 研究主任:Corinne VANNIMENUS, MD、Centre Hospitalier Régional et Universitaire LILLE
出版物和有用的链接
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.